Hatteras Venture Partners
Edit

Hatteras Venture Partners

http://www.hatterasvp.com/
Last activity: 14.04.2025
Active
Hatteras Venture Partners is a venture capital firm that builds transformational companies in the areas of biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related opportunities in human medicine. We typically invest in companies built on cutting-edge science from leading academic institutions. The firm has invested in companies across the United States in most of the major hotspots for health innovation. Given our headquarters location in RTP, NC, Hatteras plays a leadership role in building companies in North Carolina and the Southeastern United States, where technology is plentiful but resident venture capital is limited.

Core to the mission of Hatteras Venture Partners is a belief that entrepreneurial innovation will create valuable new products that will transform the practice of medicine and create value for our investors. As entrepreneurs, operators, and investors, we are dedicated to the success of our companies and to the men and women who create them.

Founded in 2000 and based in Durham, NC, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to building successful new biomedical companies. The Hatteras team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With five funds, the firm has approximately $450 million under management.

Hatteras is an Innovation to Impact sponsor of the Council for Entrepreneurial Development, a member of NCBIO, and an active volunteer in support of North Carolina and Southeast regional biotech activities.
Portfolio
1
Mentions
75
Location: United States, North Carolina, Durham
Employees: 11-50
Founded date: 2000
Investment Type: Venture Capital

Portfolio 1

DateNameWebsiteTotal RaisedLocation
18.05.2023Myeloid Th...myeloidtx.com$123MUnited Sta...

Mentions in press and media 75

DateTitleDescription
14.04.2025Atsena Therapeutics: $150 Million (Series C) Closed To Advance Ocular Gene Therapy ProgramsAtsena Therapeutics – a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness – recently announced the closing of an oversubscribed $150 million Series C fnuding....
04.04.2025Atsena Therapeutics Raises $150M in Series C FinancingAtsena Therapeutics, a Durham, NC-based clinical-stage gene therapy company, raised $150M in Series C funding. The round was led by Bain Capital’s Life Sciences team, with participation from an additional new investor, Wellington Management...
14.02.2025BEKhealth's $4 Million Boost: A Leap into the Future of Healthcare DataIn the fast-paced world of healthcare technology, innovation is the lifeblood that keeps the industry thriving. BEKhealth, a Research Triangle Park-based company, has just secured a significant $4 million in funding. This financial boost is...
14.02.2025BEKhealth Raises $4 Million to Fuel Expansion Following Strong Customer Growth in 2024BEKhealth brings an innovative AI-driven technology to transform and organize electronic health records (EHR), providing a scalable clinical data platform that optimizes performance for research networks, biopharma, and contract research or...
06.07.2024Endogenex: $88 Million Raised To Improve Outcomes In Individuals With Type 2 DiabetesEndogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes, announced it closed an oversubscribed Series C financing totaling $88 million. The new funding round will be used to com...
23.06.2021RapidPulse Launches with $15M for Ischemic Stroke Therapy– RapidPulse, Inc., a Miami-based medical device company developing a novel aspiration system to treat ischemic stroke, today announced it has raised $15M in Series A funding led by Santé Ventures who was joined by Epidarex Capital, Hattera...
15.04.2019Term Sheet — Monday, April 15FAILING THE QUIZ The latest drama out of startup-land? Of all the things, it’s a power struggle of who will lead live trivia game show startup HQ Trivia. Paid Content What you need to know about growing cyberattacks From ExtraHop HQ Trivia ...
15.04.2019Hatteras Raises $94M For Sixth FundDURHAM, N.C., April 15, 2019 (GLOBE NEWSWIRE) — Hatteras Venture Partners announced today the first closing of Hatteras Venture Partners VI, LP (HVP VI), with $94 million in deployable capital toward an ultimate target fund size of $200 mil...
15.04.2019Hatteras Raises $94M For Sixth FundDURHAM, N.C., April 15, 2019 (GLOBE NEWSWIRE) — Hatteras Venture Partners announced today the first closing of Hatteras Venture Partners VI, LP (HVP VI), with $94 million in deployable capital toward an ultimate target fund size of $200 mil...
03.01.2019Hatteras Venture Partners-backed StrideBio Appoints Sapan Shah as CEOStrideBio, Inc, a leading developer of novel adeno-associated viral (AAV) based gene therapies, announced today that the Board of Directors has appointed Sapan Shah, Ph.D. as Chief Executive Officer and a member of the company’s board. Dr S...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In